1,325
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer

, , , , ORCID Icon &
Pages 3739-3750 | Received 09 Dec 2021, Accepted 08 Jan 2022, Published online: 26 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shanwei Wang, Yanli Wang, Sheng Li, Shen Nian, Wenjing Xu & Fenli Liang. (2022) Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc. Bioengineered 13:5, pages 12115-12126.
Read now

Articles from other publishers (3)

Min Liu, Siyu Cao, Ziyi Guo, Zong Wu, Jiao Meng, Yong Wu, Yang Shao & Yanli Li. (2022) Roles and mechanisms of CircRNAs in ovarian cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Yumin Qiu, Yan Chen, Oluwatobi Agbede, Esra Eshaghi & Chun Peng. (2022) Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets. Cancers 14:22, pages 5711.
Crossref
Xuehao Zhou, Xiang Ao, Zhaojun Jia, Yiwen Li, Shouxiang Kuang, Chengcheng Du, Jinyu Zhang, Jianxun Wang & Ying Liu. (2022) Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. Frontiers in Oncology 12.
Crossref